Connection

Adviye Ergul to Stroke

Back to Details
This is a "connection" page, showing publications Adviye Ergul has written about Stroke.
Adviye Ergul
Connection Strength
8.058
Stroke
  1. Acute Ischemic Stroke by Middle Cerebral Artery Occlusion in Rat Models of Diabetes: Importance of Pre-op and Post-op Care, Severity of Hyperglycemia, and Sex. Methods Mol Biol. 2023; 2616:467-479.
    View in: PubMed
    Score: 0.340
  2. Deferoxamine prevents poststroke memory impairment in female diabetic rats: potential links to hemorrhagic transformation and ferroptosis. Am J Physiol Heart Circ Physiol. 2023 02 01; 324(2):H212-H225.
    View in: PubMed
    Score: 0.339
  3. Cerebral microvascular matrix metalloproteinase-3 (MMP3) contributes to vascular injury after stroke in female diabetic rats. Neurochem Int. 2023 01; 162:105462.
    View in: PubMed
    Score: 0.338
  4. Vascular contributions to cognitive impairment/dementia in diabetes: role of endothelial cells and pericytes. Am J Physiol Cell Physiol. 2022 10 01; 323(4):C1177-C1189.
    View in: PubMed
    Score: 0.332
  5. Impact of diabetes and ischemic stroke on the cerebrovasculature: A female perspective. Neurobiol Dis. 2022 06 01; 167:105667.
    View in: PubMed
    Score: 0.320
  6. Delayed Administration of Angiotensin Receptor (AT2R) Agonist C21 Improves Survival and Preserves Sensorimotor Outcomes in Female Diabetic Rats Post-Stroke through Modulation of Microglial Activation. Int J Mol Sci. 2021 Jan 29; 22(3).
    View in: PubMed
    Score: 0.297
  7. Deferoxamine Treatment Prevents Post-Stroke Vasoregression and Neurovascular Unit Remodeling Leading to Improved Functional Outcomes in Type 2 Male Diabetic Rats: Role of Endothelial Ferroptosis. Transl Stroke Res. 2021 08; 12(4):615-630.
    View in: PubMed
    Score: 0.289
  8. Microglia knockdown reduces inflammation and preserves cognition in diabetic animals after experimental stroke. J Neuroinflammation. 2020 Apr 28; 17(1):137.
    View in: PubMed
    Score: 0.282
  9. Delayed Administration of Angiotensin II Type 2 Receptor (AT2R) Agonist Compound 21 Prevents the Development of Post-stroke Cognitive Impairment in Diabetes Through the Modulation of Microglia Polarization. Transl Stroke Res. 2020 08; 11(4):762-775.
    View in: PubMed
    Score: 0.274
  10. Inflammation within the neurovascular unit: Focus on microglia for stroke injury and recovery. Pharmacol Res. 2019 09; 147:104349.
    View in: PubMed
    Score: 0.267
  11. Post-stroke neovascularization and functional outcomes differ in diabetes depending on severity of injury and sex: Potential link to hemorrhagic transformation. Exp Neurol. 2019 01; 311:106-114.
    View in: PubMed
    Score: 0.252
  12. Inhibition of Toll-Like Receptor-4 (TLR-4) Improves Neurobehavioral Outcomes After Acute Ischemic Stroke in Diabetic Rats: Possible Role of Vascular Endothelial TLR-4. Mol Neurobiol. 2019 Mar; 56(3):1607-1617.
    View in: PubMed
    Score: 0.248
  13. Response to Letter Regarding Article, "Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke". Stroke. 2016 06; 47(6):e173.
    View in: PubMed
    Score: 0.214
  14. Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes. Transl Stroke Res. 2016 08; 7(4):248-60.
    View in: PubMed
    Score: 0.213
  15. Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke. Stroke. 2016 Mar; 47(3):843-51.
    View in: PubMed
    Score: 0.210
  16. Cellular connections, microenvironment and brain angiogenesis in diabetes: Lost communication signals in the post-stroke period. Brain Res. 2015 Oct 14; 1623:81-96.
    View in: PubMed
    Score: 0.197
  17. Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA. Transl Stroke Res. 2015 Jun; 6(3):171-80.
    View in: PubMed
    Score: 0.197
  18. SOD1 overexpression prevents acute hyperglycemia-induced cerebral myogenic dysfunction: relevance to contralateral hemisphere and stroke outcomes. Am J Physiol Heart Circ Physiol. 2015 Mar 01; 308(5):H456-66.
    View in: PubMed
    Score: 0.195
  19. Metformin treatment in the period after stroke prevents nitrative stress and restores angiogenic signaling in the brain in diabetes. Diabetes. 2015 May; 64(5):1804-17.
    View in: PubMed
    Score: 0.194
  20. Reply to "Letter to the editor: 'Targeting cerebrovascular myogenic dysfunction in stroke'". Am J Physiol Heart Circ Physiol. 2014 May 15; 306(10):H1483.
    View in: PubMed
    Score: 0.187
  21. Hyperglycemia, acute ischemic stroke, and thrombolytic therapy. Transl Stroke Res. 2014 Aug; 5(4):442-453.
    View in: PubMed
    Score: 0.184
  22. Cerebral neovascularization in diabetes: implications for stroke recovery and beyond. J Cereb Blood Flow Metab. 2014 Apr; 34(4):553-63.
    View in: PubMed
    Score: 0.183
  23. Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats. Brain Res. 2013 Dec 06; 1541:106-14.
    View in: PubMed
    Score: 0.179
  24. Protein nitration impairs the myogenic tone of rat middle cerebral arteries in both ischemic and nonischemic hemispheres after ischemic stroke. Am J Physiol Heart Circ Physiol. 2013 Dec; 305(12):H1726-35.
    View in: PubMed
    Score: 0.179
  25. Vascularization pattern after ischemic stroke is different in control versus diabetic rats: relevance to stroke recovery. Stroke. 2013 Oct; 44(10):2875-82.
    View in: PubMed
    Score: 0.177
  26. Recommendations for preclinical research in hemorrhagic transformation. Transl Stroke Res. 2013 Jun; 4(3):322-7.
    View in: PubMed
    Score: 0.175
  27. Cerebrovascular complications of diabetes: focus on stroke. Endocr Metab Immune Disord Drug Targets. 2012 Jun; 12(2):148-58.
    View in: PubMed
    Score: 0.163
  28. Angiogenesis: a harmonized target for recovery after stroke. Stroke. 2012 Aug; 43(8):2270-4.
    View in: PubMed
    Score: 0.163
  29. The effect of endothelin receptor A antagonism on basilar artery endothelium-dependent relaxation after ischemic stroke. Life Sci. 2012 Oct 15; 91(13-14):676-80.
    View in: PubMed
    Score: 0.160
  30. Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature. Vascul Pharmacol. 2009 Jul; 51(1):44-9.
    View in: PubMed
    Score: 0.130
  31. Tactics for vascular protection after acute ischemic stroke. Pharmacotherapy. 2005 Mar; 25(3):387-95.
    View in: PubMed
    Score: 0.099
  32. Contralesional angiotensin type 2 receptor activation contributes to recovery in experimental stroke. Neurochem Int. 2022 09; 158:105375.
    View in: PubMed
    Score: 0.082
  33. Stimulation of angiotensin II receptor 2 preserves cognitive function and is associated with an enhanced cerebral vascular density after stroke. Vascul Pharmacol. 2021 12; 141:106904.
    View in: PubMed
    Score: 0.077
  34. Stroke promotes the development of brain atrophy and delayed cell death in hypertensive rats. Sci Rep. 2020 11 19; 10(1):20233.
    View in: PubMed
    Score: 0.073
  35. Angiotensin receptor (AT2R) agonist C21 prevents cognitive decline after permanent stroke in aged animals-A randomized double- blind pre-clinical study. Behav Brain Res. 2019 02 01; 359:560-569.
    View in: PubMed
    Score: 0.063
  36. Dose-response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: A randomized, blinded preclinical trial in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab. 2019 08; 39(8):1635-1647.
    View in: PubMed
    Score: 0.061
  37. Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension. PLoS One. 2017; 12(6):e0178867.
    View in: PubMed
    Score: 0.058
  38. Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental Stroke. Mol Neurobiol. 2017 01; 54(1):661-670.
    View in: PubMed
    Score: 0.052
  39. Low-dose candesartan enhances molecular mediators of neuroplasticity and subsequent functional recovery after ischemic stroke in rats. Mol Neurobiol. 2015; 51(3):1542-53.
    View in: PubMed
    Score: 0.047
  40. Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition. Am J Physiol Regul Integr Comp Physiol. 2014 Sep 15; 307(6):R693-703.
    View in: PubMed
    Score: 0.047
  41. Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. Mol Neurobiol. 2015 Apr; 51(2):766-78.
    View in: PubMed
    Score: 0.047
  42. Remote ischemic perconditioning is effective after embolic stroke in ovariectomized female mice. Transl Stroke Res. 2014 Aug; 5(4):484-90.
    View in: PubMed
    Score: 0.046
  43. Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke. Neurochem Res. 2013 Dec; 38(12):2668-77.
    View in: PubMed
    Score: 0.045
  44. Response to letter regarding article, "Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type". Stroke. 2013 Apr; 44(4):e37.
    View in: PubMed
    Score: 0.043
  45. Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke. Stroke. 2012 Oct; 43(10):2794-9.
    View in: PubMed
    Score: 0.041
  46. Vascular protection by angiotensin receptor antagonism involves differential VEGF expression in both hemispheres after experimental stroke. PLoS One. 2011; 6(9):e24551.
    View in: PubMed
    Score: 0.039
  47. Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke. 2011 Sep; 42(9):2633-5.
    View in: PubMed
    Score: 0.038
  48. Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke. 2010 Oct; 41(10):2283-7.
    View in: PubMed
    Score: 0.036
  49. Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential. Stroke. 2009 Sep; 40(9):3028-33.
    View in: PubMed
    Score: 0.033
  50. Diet-induced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke. Microvasc Res. 2009 Jun; 78(1):100-6.
    View in: PubMed
    Score: 0.033
  51. Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke. Stroke. 2009 May; 40(5):1870-6.
    View in: PubMed
    Score: 0.033
  52. Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci. 2006 Jul 17; 7:56.
    View in: PubMed
    Score: 0.027
  53. Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke. BMC Neurosci. 2005 Aug 03; 6:49.
    View in: PubMed
    Score: 0.025
  54. Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke. Am J Physiol Regul Integr Comp Physiol. 2004 Feb; 286(2):R283-8.
    View in: PubMed
    Score: 0.022
  55. Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B. J Pharmacol Exp Ther. 2014 Jun; 349(3):444-57.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.